The pharmacokinetics of methanol in the presence of ethanol: a case study.

Carolyn V Coulter, Geoffrey K Isbister, Stephen B Duffull
Author Information
  1. Carolyn V Coulter: School of Pharmacy, University of Otago, Dunedin, New Zealand. carolyn.coulter@otago.ac.nz

Abstract

BACKGROUND AND OBJECTIVE: Methanol is a toxic alcohol that can cause significant morbidity and mortality in overdose, while ethanol is a readily available and effective antidote. Little is known about the pharmacokinetics of methanol in the presence of ethanol and vice versa. This paper explores the influence of methanol and ethanol on the pharmacokinetics of each other along with the effect of continuous venovenous haemodiafiltration (CVVHD) on alcohol removal.
METHODS: Multiple plasma, urine and dialysate samples were collected from a 42-year-old male who ingested 166 g of methanol. Methanol and ethanol concentrations in both plasma and urine were assayed and the concentration-time data were modelled using nonlinear mixed-effects modelling software NONMEM® VI. Simulations were performed using the final model parameters in MATLAB® software where a variety of initial doses and ethanol infusions were assessed.
RESULTS: The final model included a competitive metabolic interaction between methanol and ethanol as well as first-order elimination due to renal, CVVHD and an additional non-renal non-CVVHD mechanism. Simulations from the model show a loading dose of 28.4 g/70 kg of ethanol results in a target plasma concentration of 1 g/L. Due to the competitive interaction between methanol and ethanol, higher amounts of methanol require lower maintenance doses of ethanol but for longer. CVVHD was shown to increase the dose rate of ethanol required but to decrease the duration of the maintenance phase.
CONCLUSION: A detailed understanding of the pharmacokinetics of methanol and ethanol in the presence of each other is required to accurately determine the doses of ethanol required to treat different methanol poisonings.

References

  1. Clin Pharmacokinet. 2003;42(1):1-31 [PMID: 12489977]
  2. N Z Med J. 2000 Jan 28;113(1102):11-3 [PMID: 10738494]
  3. Crit Rev Toxicol. 1982 Oct;10(4):275-86 [PMID: 6756793]
  4. Hum Exp Toxicol. 2005 Feb;24(2):55-9 [PMID: 15850279]
  5. Pediatrics. 2001 Jan;107(1):170 [PMID: 11134450]
  6. J Toxicol Clin Toxicol. 1997;35(2):127-43 [PMID: 9120880]
  7. J Intern Med. 2005 Aug;258(2):181-90 [PMID: 16018795]
  8. J Toxicol Clin Toxicol. 2002;40(4):415-46 [PMID: 12216995]
  9. N Engl J Med. 2001 Feb 8;344(6):424-9 [PMID: 11172179]
  10. J Emerg Med. 2003 May;24(4):433-6 [PMID: 12745047]
  11. Toxicol Sci. 2005 May;85(1):476-90 [PMID: 15716482]
  12. Crit Care Nurse. 2000 Dec;20(6):41-7 [PMID: 11878258]
  13. J Toxicol Clin Toxicol. 2003;41(6):793-800 [PMID: 14677789]
  14. Int J Legal Med. 1992;105(2):111-4 [PMID: 1520634]
  15. Clin Pharmacokinet. 1987 Nov;13(5):273-92 [PMID: 3319346]
  16. N Engl J Med. 2009 May 21;360(21):2216-23 [PMID: 19458366]
  17. J Toxicol Clin Toxicol. 2001;39(6):627-31 [PMID: 11762672]
  18. Intensive Care Med. 2005 Feb;31(2):189-95 [PMID: 15627163]
  19. Arch Toxicol. 2000 Aug;74(6):313-21 [PMID: 11005677]
  20. West J Med. 1985 Mar;142(3):337-40 [PMID: 3993008]
  21. Arch Toxicol. 1998 Sep;72(9):604-7 [PMID: 9806434]
  22. Biochemistry. 1983 Apr 12;22(8):1857-63 [PMID: 6342669]
  23. Am J Med. 1980 Mar;68(3):414-8 [PMID: 7361809]
  24. Nephrol Dial Transplant. 2003 Dec;18(12):2665-7 [PMID: 14605295]
  25. J Clin Pharmacol. 2009 Feb;49(2):130-7 [PMID: 19004845]
  26. Pharmacotherapy. 2002 Mar;22(3):365-72 [PMID: 11899949]

MeSH Term

Adult
Alcoholism
Antidotes
Computer Simulation
Dialysis Solutions
Drug Administration Schedule
Drug Interactions
Drug Monitoring
Ethanol
Hemodiafiltration
Humans
Male
Metabolic Clearance Rate
Methanol
Models, Biological
Solvents

Chemicals

Antidotes
Dialysis Solutions
Solvents
Ethanol
Methanol

Word Cloud

Created with Highcharts 10.0.0ethanolmethanolpharmacokineticspresenceCVVHDplasmamodeldosesrequiredMethanolalcoholurineusingsoftwareSimulationsfinalcompetitiveinteractiondosemaintenanceBACKGROUNDANDOBJECTIVE:toxiccancausesignificantmorbiditymortalityoverdosereadilyavailableeffectiveantidoteLittleknownviceversapaperexploresinfluencealongeffectcontinuousvenovenoushaemodiafiltrationremovalMETHODS:Multipledialysatesamplescollected42-year-oldmaleingested166 gconcentrationsassayedconcentration-timedatamodellednonlinearmixed-effectsmodellingNONMEM®VIperformedparametersMATLAB®varietyinitialinfusionsassessedRESULTS:includedmetabolicwellfirst-ordereliminationduerenaladditionalnon-renalnon-CVVHDmechanismshowloading284 g/70 kgresultstargetconcentration1 g/LDuehigheramountsrequirelowerlongershownincreaseratedecreasedurationphaseCONCLUSION:detailedunderstandingaccuratelydeterminetreatdifferentpoisoningsethanol:casestudy

Similar Articles

Cited By